By providing free drugs called ACE inhibitors to people with diabetes, Medicare would both save money and save lives, researchers say. Even if officials don't agree, the upcoming Medicare drug benefit might at least get these valuable therapies into the hands of a few more seniors in need.

Although Alzheimer's disease and stem-cell research are receiving extraordinary media and political attention because of the upcoming election, the real politics of aging-related research lie largely outside the current presidential race.